http://clinicalimmunologyinfo.com/topic/thomson-reuters-corporation2011-07-15T09:01:45Z2011-07-15T09:01:45ZReuters US Online Report Health Newstag:clinicalimmunologyinfo.com,2011-07-15:/lupus/landmark-lupus-drug-benlysta-approved-europe-4806979a/

<div><p><span>LONDON</span> (<span><a title="Thomson Reuters Corporation" href="/topic/Thomson+Reuters+Corporation" >Reuters</a></span>) - <a title="Benlysta" href="/topic/Benlysta" >Benlysta</a>, the first new treatment for lupus in half a century, was approved for use in <span><a title="Europe" href="/topic/Europe" >Europe</a></span>, the drug's discoverer <span><a title="Human Genome Sciences Inc." href="/topic/Human+Genome+Sciences+Inc." >Human Genome Sciences</a></span> and partner <span><a...

2010-04-09T14:33:37ZZUMA Press Inctag:clinicalimmunologyinfo.com,2010-04-09:/photo/china-opens-financial-news-media-997740p/

Nov 14, 2008 - <a title="Shanghai" href="/topic/Shanghai" >Shanghai</a>, <a title="China" href="/topic/China" >China</a> - China has opened its market to financial information providers, ending an attempt to give the official <a title="Xinhua News Agency" href="/topic/Xinhua+News+Agency" >Xinhua news agency</a> tight control over its foreign competitors and resolving a trade dispute with the <a title="United States" href="/topic/United+States" >US</a>, the <a title="European Union" href="/topic/...